Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | PRKCA | P17252 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28658685 | 1.00 | LMNA (0.33) | LMNACHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL28331579 | 0.84 | MAPT (0.35) | LMNACHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL11520643 | 0.84 | MAPT (0.35) | LMNACHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL2480097 | 0.83 | — | — | |
| SCHEMBL18343830 | 0.81 | — | — | |
| SCHEMBL28522874 | 0.80 | MAPT (0.33) | LMNACHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL31232292 | 0.80 | ANPEP (0.33) | LMNACHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL1437005 | 0.80 | MAPT (0.41) | LMNACHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL28772648 | 0.77 | MAPT (0.35) | LMNACHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL28502070 | 0.77 | MAPT (0.47) | MAPTPRKCAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113710687-A | Cyclopeptide antibiotics | 豪夫迈·罗氏有限公司 | 2021-11-26 | — | — | CN | disclosed |